Scientific Poster Session III: Students Research-in-Progress

Students Research in Progress
  Monday, November 13, 2023
  01:00 PM–02:30 PM

Abstract

Introduction: Heart failure (HF) is commonly associated with frequent hospitalizations and cost. Healthcare systems have explored outpatient clinics as an alternative to hospitalization. These clinics manage oral and intravenous diuretics for CHF patients. However, the efficacy and safety of interdisciplinary diuresis clinics is not known.

Research Question or Hypothesis: What is the potential clinical, economic impact of referring patients to an interdisciplinary IV heart failure diuresis clinic on hospital readmission rates, GDMT optimization, and safety compared to inpatient diuresis.

Study Design: Single center retrospective cohort

Methods: This is a research in progress. Two cohorts of about 220 number of CHF patients enrolled in theIV diuresis CHF clinic and 220 seen in the hospital for IV diuresis from 10/15/2021 to10/15/2022 were included. Outcome data such as CHF GDMT optimization, repeat hospital utilization, repeat need for IV diuresis, safety events associated with IV diuresis, and economic utilization for diuresis services will be collected until 7/1/2023. Cost will be calculated via hospital accounts.

Results: There were 220 clinic diuresis patients and 220 patients in the hospital diuresis only patients identified and included in this study. The clinic population has been evaluated as research in progress. There were 68 (30.9%) clinic patients with a reduced ejection fraction. There were 84clinic patients (38.2%) who were indicated for IV diuresis. There were 23 (27.4%) of hospital referred clinic patients, received outpatient IV diuresis during their 30-day CHF readmission window. There were 76 clinic patients (34.5%), who had a subsequent CHF admission from the enrollment date, until 6/1/2023. Baseline maximum medication GMDT status was increased from 7.3% at baseline enrollment to 34.0% by end of study period.

Conclusion: Access to ambulatory IV diuresis may help lower CHF hospital utilization. Future data to be included include GDMT titrations, safety, and cost-savings compared with a hospital only managed cohort.

Presenting Author

Mehek Yousaf Biological Sciences Bachelors of Science
University of Maryland, Baltimore

Authors

Elizabeth Pate CRNP
Baltimore Washington Medical Center

Jorge Perez-Alard MD
Baltimore Washington Medical Center

Paul Solinsky PharmD, BCACP
University of Maryland School of Pharmacy